Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.

Systemic non-Hodgkin lymphoma in HIV-infected patients with effective suppression of HIV replication: persistent occurrence but improved survival.

Gérard L, Galicier L, Maillard A, Boulanger E, Quint L, Matheron S, Cardon B, Meignin V, Oksenhendler E.

J Acquir Immune Defic Syndr. 2002 Aug 15;30(5):478-84.

PMID:
12154338
3.

Improved survival in HIV-related Hodgkin's lymphoma since the introduction of highly active antiretroviral therapy.

Gérard L, Galicier L, Boulanger E, Quint L, Lebrette MG, Mortier E, Meignin V, Oksenhendler E.

AIDS. 2003 Jan 3;17(1):81-7.

PMID:
12478072
5.

The clinical epidemiology of Hodgkin lymphoma in HIV-infected patients in the highly active antiretroviral therapy (HAART) era.

Vilchez RA, Finch CJ, Jorgensen JL, Butel JS.

Medicine (Baltimore). 2003 Mar;82(2):77-81.

6.

Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy.

Antinori A, Cingolani A, Alba L, Ammassari A, Serraino D, Ciancio BC, Palmieri F, De Luca A, Larocca LM, Ruco L, Ippolito G, Cauda R.

AIDS. 2001 Aug 17;15(12):1483-91.

PMID:
11504980
7.

Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia.

Robotin MC, Law MG, Milliken S, Goldstein D, Garsia RJ, Dolan GM, Kaldor JM, Grulich AE.

HIV Med. 2004 Sep;5(5):377-84.

8.

[Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003].

Jacomet C, Lesens O, Villemagne B, Darcha C, Tournilhac O, Henquell C, Cormerais L, Gourdon F, Peigue-Lafeuille H, Travade P, Beytout J, Laurichesse H.

Med Mal Infect. 2006 Mar;36(3):157-62. French.

PMID:
16503104
9.

Impact of highly active antiretroviral therapy in the treatment of HIV-infected patients with systemic non-Hodgkin's lymphoma.

Baiocchi OC, Colleoni GW, Navajas EV, Duarte LC, Alves AC, Andrade AL, Kerbauy J, Oliveira JS.

Acta Oncol. 2002;41(2):192-6.

PMID:
12102166
10.
12.

AIDS and non-Hodgkin's lymphoma. Experience at an oncological center in Mexico.

Cornejo-Juárez P, Volkow-Fernández P, Avilés-Salas A, Calderón-Flores E.

Rev Invest Clin. 2008 Sep-Oct;60(5):375-81.

PMID:
19227434
13.

Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy.

Lim ST, Karim R, Tulpule A, Nathwani BN, Levine AM.

J Clin Oncol. 2005 Nov 20;23(33):8477-82.

PMID:
16230675
14.

[Non-Hodgkin lymphomas with systemic presentation in patients with HIV infection. Clinical and prognostic factors in a series evaluated before the introduction of the highly active antiretroviral therapy (HAART)].

Segura Huerta A, López Tendero P, Romera Barroso B, Yuste Izquierdo AL, Gironés Sarrió R, Pérez Fidalgo JA, Gómez Codina J, López Aldeguer J.

Rev Clin Esp. 2004 Jun;204(6):303-7. Spanish.

PMID:
15171891
15.

Non-Hodgkin's lymphoma in patients with human immunodeficiency virus infection in Taiwan.

Yang CJ, Chen MY, Hsieh SM, Sheng WH, Sun HY, Hung CC, Chang SC.

J Microbiol Immunol Infect. 2010 Aug;43(4):278-84. doi: 10.1016/S1684-1182(10)60044-8.

16.

The Changing Clinical Spectrum of Human Immunodeficiency Virus (HIV)-Related Oral Lesions in 1,000 Consecutive Patients: A 12-Year Study in a Referral Center in Mexico.

Ramírez-Amador V, Esquivel-Pedraza L, Sierra-Madero J, Anaya-Saavedra G, González-Ramírez I, Ponce-de-León S.

Medicine (Baltimore). 2003 Jan;82(1):39-50.

18.

[Systemic HIV-non-Hodgkin lymphoma in the era of HAART. Natural history].

Juzbasic S, Spina M, Vaccher E, Tirelli U.

Recenti Prog Med. 2001 Nov;92(11):676-89. Review. Italian.

PMID:
11765662

Supplemental Content

Support Center